Move over, Viagra—there’s a new player in town, and it works *way* faster.  

Aspargo Labs just dropped exciting results from their Phase 1 trial for **ASP-001**, an investigational **sildenafil oral spray** designed to treat erectile dysfunction (ED). The best part? It starts working in **just 5 minutes**—blowing traditional Viagra tablets out of the water.  

### **Why This is a Big Deal**  
For years, men with ED have had to plan ahead, timing their meds around meals and waiting for the pill to kick in. But ASP-001 flips the script with **rapid absorption**, hitting therapeutic levels *twice as fast* as the classic tablet.  

Dr. Steven Kaplan, Aspargo’s Chief Medical Officer (and a top men’s health expert at Mount Sinai), put it best:  
*"Imagine not having to schedule intimacy around a pill. This spray could be a game-changer, giving couples back the spontaneity they’ve been missing."*  

### **The Science Behind the Speed**  
In the study, **53 healthy men** were given either ASP-001 or a standard 100mg Viagra tablet. The results?  

• **Within 5 minutes**, ASP-001 was already detectable in the bloodstream (0.615 ng/mL), while the tablet group? **Zero.** Nada.  
  - The spray kept higher drug levels for the **first 30 minutes**, meaning faster action when it matters most.  

### **What’s Next?**  
Aspargo isn’t stopping here. They’re already testing how food affects ASP-001’s absorption (because who wants to skip date night dinner?). Plus, they’re gearing up to file for **FDA approval**, with plans to expand into Japan, the Middle East, and South America.  

Michael Demurjian, Aspargo’s CEO, teased:  
*"Our spray isn’t just convenient—it’s *science* working smarter. We can’t wait to bring this to the U.S. market."*  

### **The Bottom Line**  
If approved, ASP-001 could revolutionize ED treatment—**faster, simpler, and way more spontaneous.** Stay tuned for updates as this spray gets closer to hitting shelves!  

---  
**Sources:**  
1. [Aspargo Labs Press Release (July 2024)](https://aspargolabs.com/investor/aspargo-labs-announces-data-on-first-oral-spray-for-erectile-dysfunction-asp-001-showing-two-times-faster-absorption-compared-to-viagra-tablets/)  
2. [Aspargo Food-Effect Study Update (Dec 2023)](https://aspargolabs.com/investor/aspargo-announces-completion-of-dosing-of-all-subjects-in-sildenafil-oral-suspension-bioavailability-study-and-initiation-of-dosing-in-companion-food-effect-study/)  

*(Now *that’s* how you make medical news fun.)* 🚀